Corline Biomedical AB (CLBIO) — Free Cash Flow Generation Index
Corline Biomedical AB (CLBIO) has a Free Cash Flow Generation Index of 0.20x as of March 2024. Free cash flow of Skr461.00K represents 0% of operating cash flow (Skr2.30 Million). See Corline Biomedical AB (CLBIO) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Corline Biomedical AB Free Cash Flow Generation Index (2023–2023)
Historical FCF Generation Index trend for Corline Biomedical AB across 1 annual periods. Explore Corline Biomedical AB (CLBIO) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Corline Biomedical AB (2023–2023)
Year-by-year Free Cash Flow Generation Index for Corline Biomedical AB. For the full company profile including market capitalisation, see how much is Corline Biomedical AB worth.
| Year | FCG Index | Free Cash Flow (SEK) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | -10.99x | Skr-9.73 Million | Skr886.00K | Skr10.62 Million | — |